Conference on 2nd Annual Smoking Cessation 2009

Venue: BSG Conference Centre

Location: London, United Kingdom

Event Date/Time: Jan 26, 2009 End Date/Time: Jan 27, 2009
Report as Spam


Background Info

Cigarette smoking is the leading source of preventable morbidity and premature mortality worldwide. - IMS Health

Where the product market is advancing in both mechanism and drug delivery, smoking cessation is and will continue to be high demand due to anti-smoking legislation and bans over the world. Nicotine addiction continues to be one of the hardest addictions to break with everyone at one time being subject to second hand smoke the strain on the healthcare systems is showing with governments investigating health education and therapies

A wider range of products are needed to meet smokers' needs and addictions. In addition revolutionary technologies are driving the way forward in creating innovative and effective solutions, new Nicotine replacement therapies, which are expected to hit the market around late 2009.

Working together the healthcare authorities and pharmaceuticals companies are striding forward in the battle of the smoking epidemic.

By attending the conference you will:

Explore the stages leading pharmaceutical companies advancing within the anti-smoking market

Discover the directions being taken to implement the dangers of Nicotine addiction in secure environments and hard to reach groups.

Examine potential market opportunities for new anti-smoking products

Gain knowledge of forthcoming treatments and future of Nicotine Replacement therapy

Asses the importance of implementing new health guidelines to educate the younger generation and passive smoking with in our worldwide communities

Key speakers

Dr Raafat Fahim, Chief Executive Officer, Nabi Biopharmaceuticals

Mark Tucker, Chief Executive Officer, G-Nostics

Dr Robert Walton, Department of Clinical Pharmacology, Oxford University

Richard Lawrence, OTC Business Line Manager, IMS Health

Lena Degling Wikingsson, Chief Executive Officer, Independent Phamaceutica

Qaim Zaidi, Ethic Strategy Coordinator, British Heart Foundation

Trevor Van Mierlo, Chief Executive Officer, V-CC Systems

Dr Martin Ledson, Consultant Chest Physician, Liverpool Heart and Chest Hospital

Dr Marcus Munafo, Department of Experimental Psychology, University of Bristol

Trish Jones, Smoking Advisor, Liverpool Heart and Chest Hospital

Scott Bryson, Lead Pharmaceutical Public Health, NHS Greater Glasgow & Clyde Pharmacy

Dr Su Wang, Group Head of Health, Royal Mail Group

For more information, kindly visit -

Contact Information

Bharat Book Bureau
207, Hermes Atrium, Sector 11, PO Box.54, CBD Belapur, Navi Mumbai - 400 614, India.
Phone : +91 22 2757 8668 / 2757 9438
Fax : +91 22 2757 9131
E-mail :
Website :


BSG Conference Centre, London, UK
United Kingdom